Download PDF
Thromb Haemost 1992; 67(01): 180-181
DOI: 10.1055/s-0038-1648403
Letters to the Editor
Schattauer GmbH Stuttgart

Absence of Transplacental Passage of Fragmin (Kabi) during the Second and the Third Trimesters of Pregnancy

F Forestier
*   Service de Médecine et de Biologie Foetales, Institut de Puériculture de Paris
,
Y Solé
*   Service de Médecine et de Biologie Foetales, Institut de Puériculture de Paris
,
M Aiach
**   Laboratoire d’Hémostase, Hôpital Broussais, Paris, France
,
M Alhenc Gélas
**   Laboratoire d’Hémostase, Hôpital Broussais, Paris, France
,
F Daffos
*   Service de Médecine et de Biologie Foetales, Institut de Puériculture de Paris
› Author Affiliations
Further Information

Publication History

Received 05 April 1991

Accepted after revision 18 June 1991

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Leisky EA, Swiet MJ. Thromboembolism in pregnancy and its management. Br J Haematol 1984; 57: 543-552
    CrossrefPubMedGoogle Scholar
  • 2 Priolet P, Roncato M, Aiach M, Housset E, Poissonier MH, Chavinie J. Low molecular weight heparin in veinous thrombosis during pregnancy. Br J Haematol 1986; 63: 605-606
    CrossrefPubMedGoogle Scholar
  • 3 Oakley C. Pregnancy in patients with prosthetic heart valves. Br Med J 1983; 286: 1680-1681
    CrossrefPubMedGoogle Scholar
  • 4 Villasanta LL. Thrombo-embolic disease in pregnancy. Am J Obstet Gynecol 1965; 93: 142-148
    CrossrefPubMedGoogle Scholar
  • 5 Forestier F, Daffos F, Rainaut M. Pre eclampsia and prostaglandin. Lancet 1985; 1: 1267-1268 (Letter)
    PubMedGoogle Scholar
  • 6 Ginsberg JS, Hirsh H. Use of anticoagulants during pregnancy. Chest 1989; 95: 156-160
    CrossrefPubMedGoogle Scholar
  • 7 Forestier F. Anticoagulants, femme et enfant. STV 1990; 3: 119-120
    PubMedGoogle Scholar
  • 8 Bloomfield DK. Fetal deaths and malformations associated with the use of coumarin derivatives in pregnancy. A critical review. Am J Obstet Gynecol 1970; 107: 883-888
    CrossrefPubMedGoogle Scholar
  • 9 Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of needle guided by ultrasound. A study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655-660
    CrossrefPubMedGoogle Scholar
  • 10 Forestier F, Cox W, Daffos F, Rainaut M. The assessment of fetal blood samples. Am J Obstet Gynecol 1988; 158: 1184-1188
    CrossrefPubMedGoogle Scholar
  • 11 Tein AN, Lie M, Abildgaard U. Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 1976; 8: 413-416
    CrossrefPubMedGoogle Scholar
  • 12 Krauer B, Krauer F, Hytten FE. Drug disposion and pharmacokinetics in the maternal placental fetal unit. Pharmac Ther 1980; 10: 301-328
    CrossrefPubMedGoogle Scholar
  • 13 Bonnar J, Redman CWG, Sheppard BL. Treatment for fetal growth retardation in utero with heparin and dipyridamole. Eur J Reprod Biol 1975; 5: 123-124
    PubMedGoogle Scholar
  • 14 Flessa HC, Kapstrom AB, Glueck HI, Will JJ. Placental transport of heparin. Am J Obstet Gynecol 1965; 93: 570-573
    CrossrefPubMedGoogle Scholar
  • 15 Kakkar W, Djazaen B, Fok J, Fletcher M, Scally M, Westwick J. Low molecular weight heparin and prevention of postoperative deep vein thrombosis in heparin. Br Med J 1983; 284: 375-379
    PubMedGoogle Scholar
  • 16 Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy. Study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557-560
    CrossrefPubMedGoogle Scholar
  • 17 Forestier F, Daffos F, Rainaut M, Toulemonde F. Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemostas 1987; 57: 234
    PubMedGoogle Scholar
  • 18 Andrew M, Cade J, Buchanan MR, Cerskus AL, Jefferies A, Towell ME, Hirsh J. Low molecular weight heparin does not cross the placenta. Thromb Haemostas 1983; 50: 225 (Abstr)
    PubMedGoogle Scholar
  • 19 Omri A, Delaloye JF, Andersen H, Bachmann F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemostas 1989; 61: 55-56
    PubMedGoogle Scholar